N E Bioventures Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
About N E Bioventures
N E Bioventures Private Limited (NEBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2012 and has a history of 12 years and 11 months. Its registered office is in Jorhat, Assam, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Anjana Pannala and Samirendra Phukan serve as directors at the Company.
Company Details
-
Location
Jorhat, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100AS2012PTC010949
-
Company No.
010949
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2012
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at N E Bioventures?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjana Pannala
|
Director | 27-Feb-2012 | Current |
|
Samirendra Phukan
|
Director | 27-Feb-2012 | Current |
Financial Performance of N E Bioventures.
N E Bioventures Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N E Bioventures?
In 2017, N E Bioventures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spc Biotech Private LimitedAnjana Pannala is a mutual person
-
Bahani Tea Co Pvt Ltd
Samirendra Phukan is a mutual person
-
Godavari Knowledge Park Private Limited
Samirendra Phukan is a mutual person
-
Dessoi Valley Tea And Spices Federation
Samirendra Phukan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at N E Bioventures?
Unlock and access historical data on people associated with N E Bioventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N E Bioventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N E Bioventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.